Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
| Autor: | Michikawa, Chieko, Torres-Saavedra, Pedro A., Silver, Natalie L., Harari, Paul M., Kies, Merrill S., Rosenthal, David I., Le, Quynh-Thu, Jordan, Richard C., Duose, Dzifa Y., Mallampati, Saradhi, Trivedi, Sanchit, Luthra, Rajyalakshmi, Wistuba, Ignacio I., Osman, Abdullah A., Lichtarge, Olivier, Foote, Robert L., Parvathaneni, Upendra, Hayes, D. Neil, Pickering, Curtis R., Myers, Jeffrey N. |
|---|---|
| Zdroj: | In Advances in Radiation Oncology November-December 2022 7(6) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|